© 2020 MJH Life Sciences and Cure Today. All rights reserved.
© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.
September 29, 2020
By Debu Tripathy
Understanding how the immune system controls itself has led to advances in immunotherapy.
By Mike Hennessy
Patient success stories illustrate the hope promised by cancer immunotherapy.
By Michael A. Postow
Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.
By Susan Kreimer
For some with lung cancer, immunotherapies are sparking long-lasting responses.
By Arlene Weintraub
By empowering the body to fight breast and renal cancers, immunotherapies are poised to improve the treatment landscape.
By Tony Hagen
Clinical development of prostate cancer vaccines is moving forward.
By Jill Oâ€™Donnell-Tormey
Clinical trials can provide patients with early access to promising cancer immunotherapies.
By Beth Fand Incollingo
Within the oncology community, price tags have sparked debate.